These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36478061)

  • 1. Nanosizing Coamorphous Drugs Using Top-Down Approach: The Effect of Particle Size Reduction on Dissolution Improvement.
    Wang G; Li Y; Qin Z; Liu T
    AAPS PharmSciTech; 2022 Dec; 24(1):14. PubMed ID: 36478061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triple Strategies to Improve Oral Bioavailability by Fabricating Coamorphous Forms of Ursolic Acid with Piperine: Enhancing Water-Solubility, Permeability, and Inhibiting Cytochrome P450 Isozymes.
    Yu D; Kan Z; Shan F; Zang J; Zhou J
    Mol Pharm; 2020 Dec; 17(12):4443-4462. PubMed ID: 32926628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin-Artemisinin Coamorphous Solid: Xenograft Model Preclinical Study.
    Mannava MKC; Suresh K; Kumar Bommaka M; Bhavani Konga D; Nangia A
    Pharmaceutics; 2018 Jan; 10(1):. PubMed ID: 29315234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel drug-drug coamorphous system without molecular interactions: improve the physicochemical properties of tadalafil and repaglinide.
    Su M; Xia Y; Shen Y; Heng W; Wei Y; Zhang L; Gao Y; Zhang J; Qian S
    RSC Adv; 2019 Dec; 10(1):565-583. PubMed ID: 35492562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanosizing of a drug/carrageenan complex to increase solubility and dissolution rate.
    Dai WG; Dong LC; Song YQ
    Int J Pharm; 2007 Sep; 342(1-2):201-7. PubMed ID: 17560055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coamorphous System of Florfenicol-Oxymatrine for Improving the Solubility and Dissolution Rate of Florfenicol: Preparation, Characterization and Molecular Dynamics Simulation.
    Li B; Hu Y; Guo Y; Xu R; Fang X; Xiao X; Jiang C; Lu S
    J Pharm Sci; 2021 Jun; 110(6):2544-2554. PubMed ID: 33577826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic Study on Transformation of Coamorphous Baicalein-Nicotinamide to Its Cocrystal Form.
    Ding F; Cao W; Wang R; Wang N; Li A; Wei Y; Qian S; Zhang J; Gao Y; Pang Z
    J Pharm Sci; 2023 Feb; 112(2):513-524. PubMed ID: 36150469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanosizing of drugs: Effect on dissolution rate.
    Dizaj SM; Vazifehasl Zh; Salatin S; Adibkia Kh; Javadzadeh Y
    Res Pharm Sci; 2015; 10(2):95-108. PubMed ID: 26487886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coamorphous repaglinide-saccharin with enhanced dissolution.
    Gao Y; Liao J; Qi X; Zhang J
    Int J Pharm; 2013 Jun; 450(1-2):290-5. PubMed ID: 23612357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incorporation of Complexation into a Coamorphous System Dramatically Enhances Dissolution and Eliminates Gelation of Amorphous Lurasidone Hydrochloride.
    Heng W; Su M; Cheng H; Shen P; Liang S; Zhang L; Wei Y; Gao Y; Zhang J; Qian S
    Mol Pharm; 2020 Jan; 17(1):84-97. PubMed ID: 31794225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced Physical Stability and Synchronized Release of Febuxostat and Indomethacin in Coamorphous Solids.
    Moinuddin SM; Shi Q; Tao J; Guo M; Zhang J; Xue Q; Ruan S; Cai T
    AAPS PharmSciTech; 2020 Jan; 21(2):41. PubMed ID: 31898765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ball-Milling Preparation of the Drug-Drug Solid Form of Pioglitazone-Rosuvastatin at Different Molar Ratios: Characterization and Intrinsic Dissolution Rates Evaluation.
    Muñoz Tecocoatzi MF; Páez-Franco JC; Rubio-Carrasco K; Núñez-Pineda A; Dorazco-González A; Fuentes-Noriega I; Vilchis-Néstor AR; Olvera LI; Morales-Morales D; Germán-Acacio JM
    Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coamorphous drug systems: enhanced physical stability and dissolution rate of indomethacin and naproxen.
    Löbmann K; Laitinen R; Grohganz H; Gordon KC; Strachan C; Rades T
    Mol Pharm; 2011 Oct; 8(5):1919-28. PubMed ID: 21815614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fabrication of quercetin nanocrystals: comparison of different methods.
    Kakran M; Shegokar R; Sahoo NG; Shaal LA; Li L; Müller RH
    Eur J Pharm Biopharm; 2012 Jan; 80(1):113-21. PubMed ID: 21896330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and characterization of quercetin nanocrystals.
    Sahoo NG; Kakran M; Shaal LA; Li L; Müller RH; Pal M; Tan LP
    J Pharm Sci; 2011 Jun; 100(6):2379-90. PubMed ID: 21491450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving the Solubility, Dissolution, and Bioavailability of Ibrutinib by Preparing It in a Coamorphous State With Saccharin.
    Shi X; Song S; Ding Z; Fan B; Huang W; Xu T
    J Pharm Sci; 2019 Sep; 108(9):3020-3028. PubMed ID: 31067482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanosizing techniques for improving bioavailability of drugs.
    Al-Kassas R; Bansal M; Shaw J
    J Control Release; 2017 Aug; 260():202-212. PubMed ID: 28603030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanodispersions of taxifolin: impact of solid-state properties on dissolution behavior.
    Shikov AN; Pozharitskaya ON; Miroshnyk I; Mirza S; Urakova IN; Hirsjärvi S; Makarov VG; Heinämäki J; Yliruusi J; Hiltunen R
    Int J Pharm; 2009 Jul; 377(1-2):148-52. PubMed ID: 19426789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coamorphous atorvastatin calcium to improve its physicochemical and pharmacokinetic properties.
    Shayanfar A; Ghavimi H; Hamishekar H; Jouyban A
    J Pharm Pharm Sci; 2013; 16(4):577-87. PubMed ID: 24210065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quercetin nanocrystals prepared using a microfluidic chip with improved in vitro dissolution.
    Zheng G; Wu W; Liu Z; Lv Y; Luo Y; Che X; Wang L
    Pharm Dev Technol; 2024 Mar; 29(3):143-152. PubMed ID: 38353125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.